Long-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

For those who have struggled with the scale, the treatments can help achieve results and improve overall health (and do so ...

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Garner, MD, Medical Director at SimpleFixRx to review it all for accuracy. Dr, Garner said, "Glucagon-like peptide-1 (GLP-1) ...